CAPS Rating

CheapHessian (< 20)

Results 1 - 20 of 45 : 1 2 3 Next »
Top Pick Start Date Ticker CAPS Rating Call Time Frame Start Price Today (Change) Stock Gain Index Gain Score End Date Pitch
17/03/2014 TGD.US 2 out of 5 Outperform 5Y $1.70 $0.25 (-0.48%) -85.31% +13.28% -98.59
17/03/2014 FNV.US 3 out of 5 Outperform 5Y $50.72 $62.81 (-0.99%) +23.84% +13.28% +10.55
17/03/2014 GDXJ.US 3 out of 5 Outperform 5Y $43.69 $32.89 (-4.83%) -24.72% +13.28% -38.00
17/03/2014 LODE.US 1 out of 5 Outperform 5Y $1.94 $0.35 (-3.59%) -81.86% +13.28% -95.14
17/03/2014 AEM.US 2 out of 5 Outperform 5Y $33.55 $44.14 (-2.06%) +31.56% +13.28% +18.28
17/03/2014 ANVGQ.US 2 out of 5 Outperform 5Y $6.37 $0.04 (0%) -99.39% +13.28% -112.67
17/03/2014 GG.US 3 out of 5 Outperform 5Y $27.15 $16.60 (-1.78%) -38.85% +13.28% -52.13
29/02/2012 16/03/2014 AMZN.US 4 out of 5 Underperform 3Y $179.70 $712.24 (-0.37%) +296.35% +53.08% -243.27
26/02/2013 EXK.US 3 out of 5 Outperform 5Y $6.21 $3.05 (-6.44%) -50.89% +40.42% -91.31
11/02/2013 FSM.US 2 out of 5 Outperform 5Y $4.47 $5.49 (-5.34%) +22.82% +38.55% -15.73
11/02/2013 PAAS.US 3 out of 5 Outperform 5Y $15.62 $13.67 (-4.14%) -12.50% +38.55% -51.06
05/02/2013 RIC.US 2 out of 5 Outperform 5Y $3.20 $7.38 (-3.78%) +130.62% +39.83% +90.79
05/02/2013 AXU.US 2 out of 5 Outperform 5Y $4.58 $1.09 (-3.54%) -76.20% +39.83% -116.03
04/02/2013 SSRI.US 3 out of 5 Outperform 5Y $12.09 $8.71 (-6.65%) -27.96% +39.86% -67.82
04/02/2013 GORO.US 1 out of 5 Outperform 5Y $10.89 $2.98 (-5.70%) -72.64% +39.86% -112.50
24/01/2013 SGSVF.US 4 out of 5 Outperform 5Y $2.51 $1.09 (-6.03%) -56.59% +40.96% -97.55
23/01/2013 NRT.US 5 out of 5 Outperform 1Y $18.18 $8.72 (-1.91%) -52.04% +40.98% -93.02
23/01/2013 CPE.US 2 out of 5 Outperform 5Y $5.22 $11.47 (-2.30%) +119.73% +40.98% +78.75
23/01/2013 POT.US 5 out of 5 Outperform 5Y $35.51 $16.57 (-0.96%) -53.34% +40.98% -94.32
14/01/2013 IAG.US 3 out of 5 Outperform 5Y $10.58 $3.17 (-5.93%) -70.04% +43.13% -113.17
Results 1 - 20 of 45 : : 1 2 3 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.